Form 4 for AGL agilon health, inc.
Accepted 2023-03-17 00:00:00 ET · period of report 2023-03-15 · accession 0001209191-23-019726 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-17 | 2023-03-15 | AGL | Wulf John William | Dir | S - Sale+OE | $23.82 | -80.0K | 123.4K | -39% | -$1.91M |
| D | 2023-03-17 | 2023-03-15 | AGL | Wulf John William | Dir | M - OptEx | $4.50 | +80.0K | 203.4K | +65% | +$360.0K |
| D | 2023-03-17 | 2023-03-15 | AGL | Wulf John William | Dir | M - OptEx | $0.00 | -80.0K | 120.0K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-15 | S | D | 80,000 | $23.82 | 123,392 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.68 to $23.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2023-03-15 | M | A | 80,000 | $4.50 | 203,392 | D | — | — | (F1) Includes restricted stock units. |
| 3 | Derivative | Options (Rights to Buy) | 2023-03-15 | M | D | 80,000 | $0.00 | 120,000 | D | $4.50 · — to 2030-05-22 | 80,000 Common Stock | (F3) These options were granted on May 22, 2020, and vest on the first five anniversaries of the grant date, subject to continued service as a director. |